Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VVOS Vivos Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.15 +0.7% | $15.90 -2.5% |
| StockIQ Score | 44D Weak Risk: High | 41D Weak Risk: High |
| Technical | 32F | 36F |
| Fundamental | 37F | 35F |
| Growth | 45D+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 32F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Vivos Therapeutics (VVOS) scores slightly higher in growth (45 vs. 50) and valuation (50 vs. 38), suggesting stronger potential upside and perceived affordability. However, Ascentage Pharma (AAPG) leads in technicals (36 vs. 32) and fundamentals (35 vs. 37), indicating more stable trading patterns and solid core business metrics. Both carry a "WEAK" rating, but AAPG’s growth score is tied with VVOS’s valuation.
